Faeth Therapeutics Inc agreed to be sold to Sensei Biotherapeutics, announced on Feb 18, 2026.
8-KCantor Fitzgerald & Co.firm, Citigroup Global Marketsfirm, Leerink Partnersfirm and Lucid Capital Marketsfirm advised the buyer.
8-KRA Capital Managementfirm also worked on OHB Pediatrics Ltd. d/b/a Oak Hill Biodeal, on Jul 27, 2026.
8-K
At a glance
Who was on each side
SellerNot named in the sources
BuyerSensei Biotherapeutics
InvestorRA Capital Management
Buyer's adviserCantor Fitzgerald & Co.
Buyer's adviserCitigroup Global Markets
Buyer's adviserLeerink Partners
Buyer's adviserLucid Capital Markets
Parties
first 2 of 6
| Party | Role | Source |
|---|---|---|
| Sensei Biotherapeutics | Buyer | 8-K |
| RA Capital Management | Investor | 8-K |
4 more parties
Sign up free to see the first 5, or become a member to see all 6.
More deals
first 2 of 16
| Date | Deal | Firms | Source |
|---|---|---|---|
| Oct 29, 2026 | ADT Inc · Sale | Thrive Capital, Citigroup Global Markets | 8-K |
| Oct 26, 2026 | Surgery Partners, Inc · Sale | Barclays Capital, Centerview Partners | 8-K |
14 more deals
Deals with RA Capital Management, Cantor Fitzgerald & Co. and 3 more firms.
Sign up free to see the first 5, or become a member to see all 16.